Long COVID as a Mass Disability Event: Biological Mechanisms, Economic Consequences, and the Rehabilitation Imperative

The COVID-19 pandemic left behind a chronic condition whose scale qualifies it as one of
the largest disability events in modern history. Long COVID, or post-COVID-19 condition,
affects a meaningful fraction of those infected with SARS-CoV-2 and produces fatigue,
cognitive impairment, and respiratory limitation that can persist for years, fluctuate
unpredictably, and remove otherwise healthy adults from work at the peak of their productive
lives. This paper joins a biological and an economic reading of the phenomenon and asks
what both imply for rehabilitation and disability policy. We first synthesise the mechanistic
evidence, viral persistence, immune dysregulation, endothelial injury, and autonomic
dysfunction, that has moved long COVID from contested syndrome to documented multi-
system disease. We then assemble the economic evidence: population-level estimates of
symptom-cluster prevalence, labour-market withdrawal on the order of millions of workers in
the United States alone, and aggregate cost estimates in the trillions of dollars once foregone
earnings, medical spending, and lost wellbeing are counted. A simple accounting framework
formalises these components, and we discuss what its terms look like in low- and middle-
income countries, where surveillance is weakest, rehabilitation capacity thinnest, and the
condition largely invisible in official statistics. We argue that long COVID exposes a
structural mismatch between episodic, fluctuating disability and rehabilitation and benefit
systems built for stable diagnoses, and that the response, multidisciplinary rehabilitation,
paced self-management, telehealth, and disability recognition, is affordable relative to the
cost of inaction. Recommendations are offered for health systems, employers, and
researchers.